Becnel was quoted extensively last week in a New York Times newspaper article by Stephanie Saul, in reference to the settlement by Pfizer Inc. in the Bextra and Celebrex cases.
Becnel discussed the key to bringing the four year old case to a settlement, linked to the inclusion of a law firm that had the experience to bring both parties together.
|
|
Additionally, Becnel is scheduled to do a television interview for the BBC, which has contacted him to discuss the lawsuit involving formaldehyde in FEMA trailers. Becnel also has a class action lawsuit pending in that case.
Comments
Comment posters are responsible for the opinions they express and the accuracy of the information they provide. We urge comment writers to treat this as a public forum where manners matter. We encourage a collegial, non-insulting tone. All readers comments must be approved by our staff before posting to the Web site. Be aware, in accordance with the Communications Decency Act and provisions upheld in judicial appeal, that you are responsible for comments posted on this Web site. The L'Observateur is not liable for messages from third parties.
DO NOT POST:
* Potentially libelous statements or damaging innuendo.
* Obscene, explicit, or racist language.
* Personal attacks, insults or threats.
* The use of another person's real name to disguise your identity.
* Comments unrelated to the story.
Opinions, advice and all other information expressed in The L'Observateur reader comments represent the individual's own views and not necessarily those of L'Observateur. L'Observateur does not endorse and is not responsible for statements, advice or opinions offered by anyone other than authorized L'Observateur spokespersons.
Thank you for your comments!